Form 4 for AGL agilon health, inc.
Accepted 2022-07-25 00:00:00 ET · period of report 2022-07-21 · accession 0001209191-22-043105 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-25 | 2022-07-21 | AGL | Desai Veeral | Chief Strategy, Dev. Off | M - OptEx | $1.00 | +79.8K | 358.0K | +29% | +$79.8K |
| D | 2022-07-25 | 2022-07-21 | AGL | Desai Veeral | Chief Strategy, Dev. Off | S - Sale+OE | $27.50 | -79.8K | 278.2K | -22% | -$2.19M |
| D | 2022-07-25 | 2022-07-21 | AGL | Desai Veeral | Chief Strategy, Dev. Off | M - OptEx | $0.00 | -79.8K | 57.4K | -58% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-21 | M | A | 79,768 | $1.00 | 357,979 | D | — | — | (F1) Includes restricted stock units. |
| 2 | Common | Common Stock | 2022-07-21 | S | D | 79,768 | $27.50 | 278,211 | D | — | — | (F1) Includes restricted stock units. |
| 3 | Derivative | Options (Rights to Buy) | 2022-07-21 | M | D | 79,768 | $0.00 | 57,441 | D | $1.00 · — to 2027-04-27 | 79,768 Common Stock | (F3) These options were granted on April 27, 2017 and fully vested on April 27, 2021. |